01349.HK
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 2.37
−0.21%Oct 9, 2026, 09:15 UTC
Fudan Zhangjiang subscribed for a CNY 150 million Bank of China structured deposit using temporarily idle proceeds from its A-share public offering.
Source:Aug 14, 2026, 10:32 UTC
Fudan Zhangjiang Bio-Pharmaceutical reported interim results for the six months ended June 2026, with net profit of 36.895 million RMB, up 545% year-on-year.